Location: Home
  • search
  • go
  • Relate News
  • 11/15/2022Simcere and Idorsia Enter into a Licensing Agreement for Daridorexant ...
  • 11/15/2022WuXi Vaccines Buys Harbour BioMed China Facility
  • 11/14/2022CDE Issues the Technical Guidelines for Clinical R&D of Bispecific Ant...
  • 11/14/2022Snapshot of BMI System Financial Performance in 3Qs/2022
  • 11/14/2022Fire Sale! China's "Warren Buffett" Races To Sell Assets (Forbes)
  • 11/14/2022Fundraising Continued to Drop in October, No Drugmaker Raised More Tha...
  • 11/11/2022AstraZeneca Launches First Alexion Rare Disease Therapy for Patients i...
  • 11/11/2022NMPA Solicits Comments on the Special Rules for TCM Registration
  • 11/11/2022Harbour BioMed Enters into a License and Collaboration Agreement with ...
  • 11/11/2022Review of A Share-listed Chinese MedPharm Cos in Q3/2022
  • 11/11/2022PwC: Review of China's Pharmaceutical & Life Sciences M&A Deals in 202...
  • 11/10/2022AstraZeneca Reports Strong Quarterly Results with China Growth Despite...
  • 11/10/2022China's Biopharma Industry: Market Prospects, Investment Paths (China ...
  • 11/10/2022Under Geopolitics and Market Rout, Chinese Biotechs Center on Data Qua...
  • 11/9/2022China Issues the 14th Five-Year Plan for Universal Health Informatizat...
  • 11/6/2022Germany Pharma CEOs Visit China with German Chancellor Scholz
  • 11/4/2022NMPA Announces Package Insert Revision of Methotrexate Oral Formulatio...
  • 11/4/2022Recent Executive Moves
  • 11/4/2022China Clarifies Regulations for Online Prescription Drug Sales, But Th...
  • 11/3/2022NMPA Releases the Draft List of Drugs Prohibited for Online Sales for ...
  • 11/1/2022TPG Capital Asia Acquires Majority Stake in iNova Pharmaceuticals
  • 11/1/2022Pharmaniaga Partners JD.com to Enter China Healthcare Market
  • 11/1/2022China Bars Celebrities from Endorsing Products to Boost 'Traditional V...
  • 10/31/2022Big Pharma Dominated the Deals Space in September (PharmaDJ)
  • 10/31/2022Financial-related Company News Digest (October 2022)
  • 10/31/2022Novartis Abandons US PD-1 Submission Plan for Tislelizumab
  • 10/28/2022Recent Executive Moves
  • 10/27/2022NMPA Announces Package Insert Revision of Domperidone Formulations
  • 10/27/2022Semiconductor Export Curbs Hitting China To Be Followed By Biotech and...
  • 10/26/2022WuXi Bio Launches 48,000L Commercial Drug Substance Manufacturing Faci...
  • Page:35/333 Total number of articles:9989: [First][<<] [33] [34] [35] [36] [37] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group